<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>input out ratio of pharmaceutical product</title>
    <link>https://www.taxtmi.com/forum/issue?id=4717</link>
    <description>Freezing the input-output ratio for Central Excise requires using the company&#039;s standard formulation as the base and supporting the submitted ratio with regulatory product permission from the FDA and the Batch Manufacturing Record (BMR) and Batch Packing Record (BPR) demonstrating actual input and output.</description>
    <language>en-us</language>
    <pubDate>Sat, 15 Sep 2012 17:12:36 +0530</pubDate>
    <lastBuildDate>Thu, 23 Jan 2025 15:57:53 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=319034" rel="self" type="application/rss+xml"/>
    <item>
      <title>input out ratio of pharmaceutical product</title>
      <link>https://www.taxtmi.com/forum/issue?id=4717</link>
      <description>Freezing the input-output ratio for Central Excise requires using the company&#039;s standard formulation as the base and supporting the submitted ratio with regulatory product permission from the FDA and the Batch Manufacturing Record (BMR) and Batch Packing Record (BPR) demonstrating actual input and output.</description>
      <category>Discussion-Forum</category>
      <law>Central Excise</law>
      <pubDate>Sat, 15 Sep 2012 17:12:36 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/forum/issue?id=4717</guid>
    </item>
  </channel>
</rss>